The ProGirls Study

Status Completed

Clinical Trial Summary

Girls in the juvenile justice system who have high rates of delinquency, drug abuse, and trauma are particularly at risk for engaging in risky sexual behavior and for contracting HIV/AIDS or other sexually transmitted infections (STIs). No effective prevention programs for girls who have this combination of behaviors is known to exist at this time. Researchers are developing, assessing, and implementing a family-centered prevention program to decrease girls' participation in the risky behaviors associated with the spread of HIV and STIs. The program also includes a group-based training and support program for parents.

Clinical Trial Description

This study aims to test an intervention to reduce HIV/STI risk behavior among girls in the juvenile justice system with the triple-threat risk of delinquency, drug abuse, and trauma. This is a competing continuation of the ProTeens study (Preventing Drug Abuse & HIV/AIDS in Delinquent Youths: An Integrated Intervention) which focused on testing a family-centered intervention for treating HIV risk, drug use, and delinquency in boys. The current study will adapt the ProTeens intervention for girls. Girls and their parent(s) will be randomly assigned to either a family-centered intervention condition (INT; n = 100) or to an active comparison condition (n = 100) consisting of group therapy and case management (GCM). The INT condition will consist of individually administered HIV preventive intervention for adolescent girls involved in the juvenile justice system that integrally addresses delinquency, drug abuse, and trauma exposure, along with group-based training and support for parents. The girl and parent components will run concurrently for three months. The GCM condition will consist of group therapy and case management for girls provided as usual by the juvenile justice department. We will examine intervention effects on proximal outcomes measured at 12 months, the effects of childhood adversity on proximal outcomes, and the mediation of intervention effects. Longer term outcomes will be measured at 24 months. Data will be collected through in-person interviews and questionnaires from focal participants and their parents, official arrest records, and urinary analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02112201
Study type	Interventional
Source	Oregon Research Institute
Contact
Status	Completed
Phase	N/A
Start date	September 2013
Completion date	May 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05806840` - Rapid Adaptation to Prevent Drug Use	N/A
Recruiting	`NCT06003725` - Cultural Adaptation of Drug Treatment for DJJ Youth	N/A
Recruiting	`NCT05414344` - A Brief Intervention for Alcohol Users With Interpersonal Trauma	N/A
Recruiting	`NCT05768815` - Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright	N/A
Completed	`NCT05606601` - An Online Intervention Addressing Mental Health and Substance Use in University Students	N/A
Completed	`NCT03489434` - Technology-Based Prevention for Adolescents in Primary Care	N/A
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Recruiting	`NCT05899101` - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed	`NCT02990026` - Specialty Mental Health Probation in North Carolina	N/A
Not yet recruiting	`NCT06116266` - Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)	N/A
Not yet recruiting	`NCT03249428` - E-Cigarette Inner City RCT	N/A
Active, not recruiting	`NCT03129334` - Preventing Prescription Drug Abuse in Middle School Students	N/A
Completed	`NCT04183400` - Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness	N/A
Completed	`NCT01752998` - Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings	N/A
Terminated	`NCT01661517` - Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting	Phase 0
Completed	`NCT01351454` - Behavioral Depression Treatment for African American HIV-infected Substance Users	N/A
Completed	`NCT01511380` - Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth	Phase 2
Completed	`NCT01154309` - Group CBT for Depression and AOD Disorders	Phase 1
Completed	`NCT01025674` - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8	N/A
Completed	`NCT00996541` - Support To Reunite Involve and Value Each Other	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.